Home/ Shop/ Muscle & Performance/ TESAMORELIN 10 MG Peptide

Muscle & Performance

TESAMORELIN 10 MG Peptide

10MG · GHRH analog

≥99% purity by HPLC
Janoshik COA with every lot
Lot-traceable from synthesis
EU-synthesised

In stock · Lot NZM-M-0040 · ships in 3–5 working days (EU)

Available for research procurement. Supplied as a lyophilized research compound with lot-specific COA.

Specifications

Lot NumberNZM-M-0040

Purity99.2% (HPLC)

Verified byJanoshik

Synthesis Date2026-04-09

FormLyophilized powder

StorageBelow 16°C · sealed

Third Party Lab Tested

Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.

Storage & Handling

Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.

FormLyophilized powder

StorageLyophilized: below 16°C for up to 24 months. Reconstituted: refrigerate, use within 30 days.

Reconstitution

Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.

Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →

Researched Benefits

Visceral Fat Reduction up to 18% VAT reduction in HIV-associated lipodystrophy trials. IGF-1 Response Sustained Full-length GHRH(1-44) preserves native binding kinetics.

Product details

A defined GHRH analogue.

Tesamorelin is a 44-amino-acid analogue of growth hormone-releasing hormone (GHRH) with an N-terminal modification designed to resist enzymatic cleavage. It is studied through the GHRH-receptor pathway, which distinguishes its research mechanism from ghrelin-receptor agonists such as Ipamorelin.

This 10 MG Tesamorelin peptide is supplied as a lyophilized vial among the peptides range from NZM-Labs. HPLC purity analysis and mass-spectrometry identity testing are performed for every production lot, with the corresponding analytical record available by lot number. For laboratory research only.

Compound Specs

Research specification table for TESAMORELIN 10 MG Peptide
Compound	Tesamorelin
Sequence length	44 amino acids
Molecular mass	5135.9 Da
Mechanism / research class	Stabilized GHRH analogue
Example laboratory preparation	10 MG vial with 2 mL bacteriostatic water (0.9% benzyl alcohol)
Calculated concentration	5 mg per 1.0 mL
Supply format	Tesamorelin · 10 MG lyophilized research vial
Storage, lyophilized	store below 16°C for up to 24 months
Storage, reconstituted	refrigerate and use within 30 days

Quality standards

Synthesised.
Verified.
Documented.

Wireframe rendering of a research peptide vial alongside molecular structure

Verified Purity

Every lot HPLC-tested by Janoshik Analytical. Independent verification, never in-house only. Current lot: 99.2% (HPLC).

Mass-Spec Confirmed

Identity confirmed by mass spectrometry. Theoretical mass matches measured within 0.5 Da tolerance.

Lyophilized & Sealed

Supplied as lyophilized powder in a sealed crimp-cap vial for laboratory handling and storage.

Lot-Traceable

From synthesis batch to your delivery, every step is logged. Search lot NZM-M-0040 for full traceability.

Evidence base

Backed by research.
Measured in results.

Each tag opens the cited literature behind that effect. References are linked to PubMed.

up to 18%

Visceral Fat Reduction

Tesamorelin is the most-studied GHRH analog in metabolic research. The reference clinical literature reports 15–18% reduction in visceral adipose tissue (VAT) at 26 weeks in HIV-associated lipodystrophy populations.

References

Falutz J et al. Tesamorelin and visceral fat. NEJM. 2007;357(23):2359-2370. PubMed ↗

Sustained

IGF-1 Response

Unlike truncated GHRH analogs, Tesamorelin retains the full GHRH(1-44) sequence with a single stabilizing N-terminal modification, preserving native receptor binding and producing a sustained IGF-1 response in research models.

References

Stanley TL et al. Tesamorelin in HIV-associated lipodystrophy. JCEM. 2014;99(5):1815-1820. PubMed ↗

Specific to TESAMORELIN 10 MG Peptide

Questions?
We have answers.

(01)

Tesamorelin vs CJC-1295 - both are GHRH analogs?

Both are GHRH analogs but engineered differently. Tesamorelin is full-length GHRH(1-44) with a single N-terminal modification, preserving native receptor binding kinetics. CJC-1295 is truncated GHRH(1-29) with four substitutions to extend half-life. Different research designs favor different profiles.

(02)

How is the Certificate of Analysis verified?

Every lot is sent to Janoshik Analytical for independent HPLC and mass spectrometry testing. The COA you receive is theirs, not ours - searchable by lot number on our Science page, no account required.

(03)

How is the product shipped?

Lyophilized vials are shipped across the EU. Store sealed vials below 16°C after delivery. Typical delivery takes 3–5 working days.

(04)

Is this a research product?

Yes. NZM peptides are sold strictly for in vitro and animal research use only. They are not for human consumption, off-label use, or clinical application. Please consult applicable local regulations before ordering.

(05)

What is the Tesamorelin research peptide price?

The current Tesamorelin price is shown on this page. Pricing applies to B2B research procurement only and may vary by lot, format, and availability.

(06)

Can research customers buy Tesamorelin from NZM-Labs?

Yes. Research customers can order Tesamorelin through NZM-Labs for in vitro and animal research use only. It is not sold for human consumption, clinical use, or self-administration.

Researcher reviews